Diasome
PrivateLast Round
Series C
Dec 7, 2023
Est. Valuation
$86M
Total Funding Raised
$43.7M
Company Overview
Diasome is a biotechnology company that develops innovative, cell-targeted therapies aimed at treating diabetes, obesity, and other metabolic disorders through proprietary liver-targeted insulins that help manage blood sugar levels effectively.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Diasome Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Diasome Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Dec 7, 2023 | ||||
| Series B | Aug 26, 2022 | ||||
| Series B | Dec 23, 2020 | ||||
| Series A | Jul 5, 2017 | ||||
| Series B | Apr 15, 2008 |
Diasome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Quaker Partners Management | Series B |
| Devon Park BioVentures | Series B |
| Black Beret Life Sciences | Series A |
| JDRF | Series A |
| Medicxi | Series A |
| McDonald Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 5, 2017
$30M round led by Medicxi.
Diasome Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Diasome's valuation, stock price, and market status.